Patient Care

This page includes news coverage of various aspects of patient healthcare, including new technology innovations, what is working, what is not, personalized medicine and remote and telemedicine delivery. Find specific news in the areas of Care Delivery, Digital Transformation, Precision Medicine, Remote Monitoring and Telehealth.

TAVR valve’s spontaneous leaflet rupture highlights importance of long-term follow-up
Cardiologists believe this is the first time this exact complication has been reported. Even patients who present with no known risk factors, they said, should receive regular follow-up care to ensure such incidents do not go untreated.
Heart transplant patients on Medicaid face a higher risk of major complications
In addition, researchers noted, five-year mortality was inferior for patients on Medicaid when compared to patients with any other type of insurance.
Industry Watcher’s Digest
When Larry Ellison talks about healthcare AI, people invest. At least, that’s what happened after the Oracle chairman enthused over AI’s potential to cook up vaccines for cancer.
Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI
Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.
American College of Cardiology announces late-breaking clinical trials for ACC.25
The presentations will cover a variety of topics, including coronary artery disease, semaglutide, artificial intelligence, TAVR, heart failure, PCI and much more. ACC.25 takes place March 29-31 in Chicago.

Cardiologists in Spain encountered an unexpected complication in a 78-year-old transcatheter aortic valve replacement (TAVR) patient, highlighting the experience in JACC: Cardiovascular Interventions.

TAVR valve’s spontaneous leaflet rupture highlights importance of long-term follow-up

Cardiologists believe this is the first time this exact complication has been reported. Even patients who present with no known risk factors, they said, should receive regular follow-up care to ensure such incidents do not go untreated.

Heart transplant patients on Medicaid face a higher risk of major complications

In addition, researchers noted, five-year mortality was inferior for patients on Medicaid when compared to patients with any other type of insurance.

Industry Watcher’s Digest

When Larry Ellison talks about healthcare AI, people invest. At least, that’s what happened after the Oracle chairman enthused over AI’s potential to cook up vaccines for cancer.

Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.

ACC.24 sign American College of Cardiology

American College of Cardiology announces late-breaking clinical trials for ACC.25

The presentations will cover a variety of topics, including coronary artery disease, semaglutide, artificial intelligence, TAVR, heart failure, PCI and much more. ACC.25 takes place March 29-31 in Chicago.

MGMA's Anders Gilberg calls on CMS and Congress to extend telemedicine and highlights the issues involved.

Congress hesitates on long-term telemedicine expansion admid advocacy push

Congress temporarily extended telemedicine provisions until March amid lobby efforts by the Medical Group Management Association (MGMA) and others to make the provisions permanent.

Payment policies may be driving down utilization of key interventional radiology procedure

Fewer than 2% of hospitalized inpatients underwent ablation for renal cell carcinoma, despite its lower cost and other benefits.

FDA warns of risk of death associated with multiple sclerosis drugs

The agency found 82 cases of anaphylaxis associated with glatiramer acetate, sold under the brand names Copaxone and Glatopa, including 19 that emerged after patients had been taking these drugs for more than a year.